Veltek Associates, Inc.
Veltek Associates, Inc. addresses all the needs required to manage contamination control. We provide chemicals, garments, cleaning devices, laboratory services, viable monitoring, and strive to develop meaningful technical client relationships.
Veltek Associates, Inc.
(VAI) provides innovative solutions to address the control of particulate and microbial contamination in pharmaceutical and biotechnology operations worldwide. We focus on the identification and control of contamination in classified areas.
VAI’s Sterile Chemical Manufacturing Division (SCMD) produces a complete range of sterile disinfectants, sanitizers, sporicides, lubricants, cleaners, detergents (CIP), and buffer solutions. We offer hand sanitizers and hands-free dispensing systems in addition to developing the Core2Clean Plus System that can spray, mop or fog in one device.
VAI’s Environmental Control Monitoring Division (ECMD) designs an assortment of viable air sampling equipment. This product line includes portable devices, compressed air sampling, and facility wide monitoring systems with numerous possibilities to maximize the use of EM information.
VAI’s Disposable Products Manufacturing Division (DPMD) offers sterile cleanroom garments, face masks and nylon packaging material. These garments also come in a patented fold (Easy2Gown) that makes gowning simple and easy for your operators.
VAI Labs provides microbiological testing ranging from the identification of microorganisms to antimicrobial effectiveness studies, a disinfectant validation service.
Aseptic Processing Inc. (consulting) provides consulting services in aseptic technique, environmental monitoring, component entry systems, personnel gowning, cleaning and disinfecting systems, and media fill trials.
Veltek Associates, Inc.www.sterile.comvai@sterile.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
